| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.68 | 0.026 | 0.68 | Caspase 9 stimulant | |||
| 0.597 | 0.054 | 0.637 | Antiinflammatory | 0.637 0.044 CID_154699657 | CID_154699657 | |
| 0.572 | 0.055 | 0.572 | Apoptosis agonist | 0.257 0.206 CID_154699657 | ||
| 0.523 | 0.017 | 0.523 | Caspase 3 stimulant | |||
| 0.532 | 0.028 | 0.532 | Aldehyde oxidase inhibitor | |||
| 0.494 | 0.031 | 0.494 | Histamine release inhibitor | 0.474 0.039 CID_154699657 | ||
| 0.45 | 0.047 | 0.45 | Immunosuppressant | 0.37 0.076 CID_154699657 | ||
| 0.454 | 0.052 | 0.454 | Transcription factor NF kappa B inhibitor | 0.285 0.103 CID_154699657 | ||
| 0.384 | 0.01 | 0.384 | Lipocortins synthesis antagonist | 0.234 0.039 CID_154699657 | ||
| 0.436 | 0.073 | 0.436 | Cyclophilin D inhibitor | 0.26 0.202 CID_154699657 | ||
| 0.373 | 0.027 | 0.373 | Sodium/bile acid cotransporter inhibitor | 0.326 0.057 CID_154699657 | ||
| 0.345 | 0.004 | 0.345 | Sphingosine 1-phosphate receptor 2 agonist | 0.101 0.1 CID_154699657 | ||
| 0.351 | 0.012 | 0.351 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.335 | 0.004 | 0.335 | Estrogen receptor alpha antagonist | 0.081 0.047 CID_154699657 | ||
| 0.331 | 0.005 | 0.331 | Estrogen antagonist | 0.129 0.04 CID_154699657 | ||
| 0.36 | 0.038 | 0.36 | DNA damaging | |||
| 0.32 | 0.005 | 0.32 | Estrogen receptor beta antagonist | 0.12 0.032 CID_154699657 | ||
| 0.356 | 0.043 | 0.356 | Hypoxia-inducible factor 1 alpha inhibitor | 0.19 0.165 CID_154699657 | ||
| 0.344 | 0.032 | 0.344 | DNA synthesis inhibitor | 0.216 0.1 CID_154699657 | ||
| 0.321 | 0.015 | 0.321 | NOS3 expression enhancer | 0.163 0.061 CID_154699657 | ||
| 0.318 | 0.014 | 0.318 | Neurotrophic factor enhancer | |||
| 0.351 | 0.049 | 0.351 | Calcium channel activator | 0.206 0.205 CID_154699657 | ||
| 0.301 | 0.005 | 0.355 | Estrogen agonist | 0.355 0.004 CID_154699657 | CID_154699657 | |
| 0.311 | 0.02 | 0.311 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.343 | 0.055 | 0.343 | Spasmolytic | 0.23 0.1 CID_154699657 | ||
| 0.344 | 0.062 | 0.344 | Immunomodulator | 0.227 0.135 CID_154699657 | ||
| 0.378 | 0.097 | 0.378 | Calcium channel L-type activator | |||
| 0.31 | 0.049 | 0.31 | Transcription factor STAT3 inhibitor | |||
| 0.333 | 0.072 | 0.557 | Cholesterol antagonist | 0.557 0.024 CID_154699657 | CID_154699657 | |
| 0.308 | 0.051 | 0.308 | Transcription factor STAT inhibitor | |||
| 0.359 | 0.107 | 0.359 | 5 Hydroxytryptamine release inhibitor | |||
| 0.352 | 0.101 | 0.423 | Antibacterial | 0.423 0.067 CID_154699657 | CID_154699657 | |
| 0.254 | 0.005 | 0.254 | MAP3K9 inhibitor | 0.187 0.022 CID_154699657 | ||
| 0.307 | 0.059 | 0.31 | Antioxidant | 0.31 0.058 CID_154699657 | CID_154699657 | |
| 0.283 | 0.036 | 0.454 | RNA-directed DNA polymerase inhibitor | 0.454 0.014 CID_154699657 | CID_154699657 | |
| 0.261 | 0.015 | 0.261 | DNA intercalator | 0.181 0.032 CID_154699657 | ||
| 0.281 | 0.038 | 0.281 | Anesthetic general | |||
| 0.284 | 0.044 | 0.284 | Nitric oxide antagonist | 0.126 0.125 CID_154699657 | ||
| 0.289 | 0.051 | 0.289 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.33 | 0.097 | 0.33 | GABA C receptor rho-3 antagonist | |||
| 0.289 | 0.058 | 0.289 | Tumour necrosis factor alpha release inhibitor | 0.269 0.066 CID_154699657 | ||
| 0.241 | 0.018 | 0.241 | Topoisomerase I inhibitor | 0.118 0.057 CID_154699657 | ||
| 0.284 | 0.063 | 0.284 | Cardiotonic | |||
| 0.311 | 0.091 | 0.311 | Vasodilator, peripheral | |||
| 0.255 | 0.042 | 0.255 | Growth hormone agonist | |||
| 0.272 | 0.058 | 0.272 | Hypolipemic | |||
| 0.229 | 0.019 | 0.229 | Alkylator | 0.166 0.039 CID_154699657 | ||
| 0.236 | 0.027 | 0.236 | Topoisomerase II inhibitor | 0.124 0.063 CID_154699657 | ||
| 0.27 | 0.065 | 0.27 | Hypoglycemic | |||
| 0.261 | 0.058 | 0.261 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.229 | 0.028 | 0.229 | Interleukin 6 antagonist | |||
| 0.266 | 0.065 | 0.398 | Superoxide dismutase inhibitor | 0.398 0.027 CID_154699657 | CID_154699657 | |
| 0.222 | 0.023 | 0.222 | ATPase inhibitor | |||
| 0.216 | 0.02 | 0.216 | Arachidonic acid antagonist | 0.146 0.094 CID_154699657 | ||
| 0.206 | 0.011 | 0.207 | Adenylate cyclase stimulant | 0.207 0.011 CID_154699657 | CID_154699657 | |
| 0.271 | 0.08 | 0.271 | 5 Hydroxytryptamine release stimulant | |||
| 0.237 | 0.047 | 0.239 | Hepatoprotectant | 0.239 0.046 CID_154699657 | CID_154699657 | |
| 0.199 | 0.011 | 0.199 | Pregnane X receptor agonist | 0.169 0.027 CID_154699657 | ||
| 0.258 | 0.07 | 0.258 | Gastrin inhibitor | |||
| 0.211 | 0.024 | 0.211 | Adenylate cyclase inhibitor | |||
| 0.25 | 0.064 | 0.25 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.207 | 0.023 | 0.207 | Cystathionine beta-synthase inhibitor | |||
| 0.183 | 0.005 | 0.183 | Estrogen receptor alpha agonist | 0.048 0.018 CID_154699657 | ||
| 0.194 | 0.019 | 0.194 | UDP-glucose 4-epimerase inhibitor | |||
| 0.203 | 0.033 | 0.203 | Hexokinase inhibitor | |||
| 0.176 | 0.008 | 0.195 | Anabolic | 0.195 0.005 CID_154699657 | CID_154699657 | |
| 0.186 | 0.02 | 0.186 | MAP kinase kinase 4 inhibitor | |||
| 0.171 | 0.006 | 0.171 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.205 | 0.041 | 0.236 | Phospholipase C inhibitor | 0.236 0.028 CID_154699657 | CID_154699657 | |
| 0.176 | 0.013 | 0.176 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.079 0.052 CID_154699657 | ||
| 0.219 | 0.058 | 0.219 | Non-steroidal antiinflammatory agent | |||
| 0.178 | 0.018 | 0.178 | Photosensitizer | 0.107 0.076 CID_154699657 | ||
| 0.174 | 0.016 | 0.174 | Creatine kinase inhibitor | 0.087 0.075 CID_154699657 | ||
| 0.164 | 0.007 | 0.164 | Glutamate release inhibitor | |||
| 0.179 | 0.022 | 0.179 | Bronchodilator | |||
| 0.18 | 0.025 | 0.18 | Antineoplastic antibiotic | 0.091 0.05 CID_154699657 | ||
| 0.33 | 0.175 | 0.33 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.179 | 0.026 | 0.179 | Microtubule formation inhibitor | |||
| 0.158 | 0.006 | 0.158 | Progesterone antagonist | |||
| 0.167 | 0.015 | 0.167 | Ca2+-transporting ATPase inhibitor | |||
| 0.184 | 0.033 | 0.184 | DNA polymerase I inhibitor | |||
| 0.16 | 0.009 | 0.16 | Alcohol oxidase inhibitor | |||
| 0.157 | 0.007 | 0.157 | Estrogen receptor beta agonist | 0.151 0.007 CID_154699657 | ||
| 0.168 | 0.019 | 0.168 | DNA repair enzyme inhibitor | 0.109 0.097 CID_154699657 | ||
| 0.196 | 0.048 | 0.196 | Cholinergic | |||
| 0.191 | 0.045 | 0.191 | Melanin inhibitor | |||
| 0.232 | 0.087 | 0.232 | Aryl hydrocarbon receptor agonist | |||
| 0.256 | 0.113 | 0.256 | Interleukin 2 agonist | |||
| 0.201 | 0.059 | 0.201 | Peroxidase inhibitor | |||
| 0.165 | 0.023 | 0.165 | Antineoplastic alkaloid | |||
| 0.193 | 0.054 | 0.193 | Antipruritic | |||
| 0.177 | 0.039 | 0.177 | CF transmembrane conductance regulator agonist | |||
| 0.178 | 0.041 | 0.178 | Acetylcholinesterase inhibitor | |||
| 0.145 | 0.008 | 0.22 | Glycine receptor antagonist | 0.22 0.003 CID_154699657 | CID_154699657 | |
| 0.154 | 0.017 | 0.154 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.156 | 0.023 | 0.156 | HIV-1 integrase (Overall Integration) inhibitor | 0.1 0.055 CID_154699657 | ||
| 0.14 | 0.008 | 0.151 | Androgen agonist | 0.151 0.007 CID_154699657 | CID_154699657 | |
| 0.177 | 0.046 | 0.177 | Tubulin antagonist | |||
| 0.155 | 0.025 | 0.155 | AMP-activated protein kinase stimulant | |||
| 0.164 | 0.038 | 0.267 | Cholesterol synthesis inhibitor | 0.267 0.015 CID_154699657 | CID_154699657 | |
| 0.262 | 0.137 | 0.262 | Toll-Like receptor 7 agonist | |||
| 0.223 | 0.1 | 0.223 | Interleukin agonist | |||
| 0.134 | 0.012 | 0.134 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.153 | 0.033 | 0.153 | GABA C receptor agonist | |||
| 0.259 | 0.14 | 0.259 | Toll-Like receptor agonist | |||
| 0.249 | 0.129 | 0.249 | Apoptosis antagonist | |||
| 0.2 | 0.082 | 0.2 | MAP kinase kinase 2 inhibitor | |||
| 0.158 | 0.043 | 0.158 | Aldehyde dehydrogenase inhibitor | |||
| 0.17 | 0.057 | 0.17 | Interferon gamma antagonist | |||
| 0.128 | 0.016 | 0.128 | Aromatase inhibitor | 0.063 0.039 CID_154699657 | ||
| 0.274 | 0.162 | 0.274 | Analgesic | |||
| 0.137 | 0.026 | 0.137 | Androgen antagonist | |||
| 0.196 | 0.086 | 0.196 | Antimitotic | |||
| 0.121 | 0.012 | 0.121 | Glycine receptor agonist | |||
| 0.162 | 0.053 | 0.162 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.134 | 0.026 | 0.134 | Topoisomerase II alpha inhibitor | |||
| 0.135 | 0.029 | 0.264 | NMDA receptor antagonist | 0.264 0.008 CID_154699657 | CID_154699657 | |
| 0.165 | 0.059 | 0.165 | Protein kinase stimulant | |||
| 0.11 | 0.004 | 0.11 | Adenylate cyclase 1 inhibitor | |||
| 0.141 | 0.037 | 0.141 | Protein kinase C gamma inhibitor | |||
| 0.122 | 0.018 | 0.122 | ATPase (Vacuolar H+) inhibitor | |||
| 0.105 | 0.005 | 0.105 | Calcium channel P-type blocker | 0.06 0.057 CID_154699657 | ||
| 0.131 | 0.032 | 0.131 | Prolactin inhibitor | |||
| 0.109 | 0.01 | 0.109 | Dopamine transporter inhibitor | |||
| 0.126 | 0.029 | 0.208 | Triose-phosphate isomerase inhibitor | 0.208 0.01 CID_154699657 | CID_154699657 | |
| 0.169 | 0.074 | 0.169 | Sigma receptor agonist | |||
| 0.11 | 0.016 | 0.11 | Adrenaline uptake inhibitor | |||
| 0.176 | 0.083 | 0.176 | P-glycoprotein inhibitor | |||
| 0.186 | 0.093 | 0.222 | Anticonvulsant | 0.222 0.069 CID_154699657 | CID_154699657 | |
| 0.113 | 0.02 | 0.116 | Na+ K+ transporting ATPase inhibitor | 0.116 0.019 CID_154699657 | CID_154699657 | |
| 0.096 | 0.004 | 0.096 | Acid-sensing ion channel blocker | 0.056 0.011 CID_154699657 | ||
| 0.171 | 0.079 | 0.171 | Succinate dehydrogenase inhibitor | |||
| 0.128 | 0.037 | 0.128 | Adenylate kinase inhibitor | |||
| 0.12 | 0.029 | 0.12 | NADH dehydrogenase inhibitor | |||
| 0.11 | 0.019 | 0.11 | Beta tubulin antagonist | |||
| 0.104 | 0.014 | 0.104 | Alpha tubulin antagonist | |||
| 0.194 | 0.107 | 0.194 | Peptidyltransferase inhibitor | |||
| 0.12 | 0.033 | 0.31 | Protein kinase C zeta inhibitor | 0.31 0.005 CID_154699657 | CID_154699657 | |
| 0.097 | 0.011 | 0.097 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.059 0.03 CID_154699657 | ||
| 0.117 | 0.031 | 0.117 | Histamine N-methyltransferase inhibitor | |||
| 0.142 | 0.056 | 0.189 | Glutamate receptor antagonist | 0.189 0.029 CID_154699657 | CID_154699657 | |
| 0.123 | 0.039 | 0.123 | Sphingomyelinase inhibitor | |||
| 0.11 | 0.028 | 0.11 | Phosphofructokinase-1 inhibitor | |||
| 0.12 | 0.039 | 0.12 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.152 | 0.072 | 0.152 | Acetylcholine M1 receptor antagonist | |||
| 0.114 | 0.037 | 0.114 | Glutamate (mGluR7) agonist | |||
| 0.097 | 0.019 | 0.097 | Dopamine uptake inhibitor | |||
| 0.196 | 0.122 | 0.35 | Immunostimulant | 0.35 0.064 CID_154699657 | CID_154699657 | |
| 0.09 | 0.016 | 0.09 | Glutamate (mGluR6) antagonist | |||
| 0.141 | 0.068 | 0.141 | Amylase inhibitor | |||
| 0.091 | 0.021 | 0.091 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.131 | 0.063 | 0.131 | Cathepsin H inhibitor | |||
| 0.091 | 0.023 | 0.091 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.106 | 0.038 | 0.108 | Bile acid receptor antagonist | 0.108 0.034 CID_154699657 | CID_154699657 | |
| 0.095 | 0.028 | 0.095 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.098 | 0.032 | 0.098 | Keratolytic | |||
| 0.105 | 0.039 | 0.105 | Ornithine decarboxylase inhibitor | |||
| 0.09 | 0.024 | 0.09 | MAP kinase kinase 7 inhibitor | |||
| 0.077 | 0.012 | 0.084 | Alpha-mannosidase inhibitor | 0.084 0.01 CID_154699657 | CID_154699657 | |
| 0.144 | 0.08 | 0.144 | Heat shock protein 90 antagonist | |||
| 0.077 | 0.013 | 0.077 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.097 | 0.033 | 0.303 | NMDA 2 receptor antagonist | 0.303 0.005 CID_154699657 | CID_154699657 | |
| 0.081 | 0.02 | 0.081 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.114 | 0.052 | 0.114 | DOPA decarboxylase inhibitor | |||
| 0.094 | 0.033 | 0.094 | Estrogen-related receptor beta agonist | |||
| 0.165 | 0.104 | 0.165 | Psychostimulant | |||
| 0.069 | 0.009 | 0.069 | Glucocorticoid antagonist | |||
| 0.076 | 0.018 | 0.076 | Glucosylceramidase inhibitor | |||
| 0.096 | 0.038 | 0.096 | mTOR complex 2 inhibitor | |||
| 0.143 | 0.086 | 0.33 | Protein-tyrosine phosphatase inhibitor | 0.33 0.014 CID_154699657 | CID_154699657 | |
| 0.072 | 0.016 | 0.072 | Topoisomerase II beta inhibitor | |||
| 0.08 | 0.025 | 0.08 | Argininosuccinate synthase inhibitor | |||
| 0.068 | 0.013 | 0.068 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.121 | 0.066 | 0.121 | Acetylcholine muscarinic antagonist | |||
| 0.072 | 0.017 | 0.072 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.138 | 0.084 | 0.138 | Heat shock protein 70 antagonist | |||
| 0.073 | 0.019 | 0.073 | Sphingosine kinase 2 inhibitor | |||
| 0.11 | 0.057 | 0.11 | Beta glucuronidase inhibitor | |||
| 0.062 | 0.01 | 0.062 | Alpha 1d adrenoreceptor agonist | |||
| 0.18 | 0.128 | 0.18 | Nitric-oxide synthase stimulant | |||
| 0.064 | 0.014 | 0.071 | Mannosidase inhibitor | 0.071 0.011 CID_154699657 | CID_154699657 | |
| 0.164 | 0.115 | 0.164 | Insulin sensitizer | |||
| 0.066 | 0.017 | 0.066 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.061 | 0.013 | 0.061 | Geranyltranstransferase inhibitor | |||
| 0.121 | 0.073 | 0.121 | Cholinergic antagonist | |||
| 0.111 | 0.063 | 0.111 | GABA C receptor antagonist | |||
| 0.053 | 0.006 | 0.053 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.123 | 0.076 | 0.123 | Cyclooxygenase 2 inhibitor | |||
| 0.053 | 0.007 | 0.053 | Vanilloid 3 antagonist | |||
| 0.161 | 0.116 | 0.741 | Angiogenesis stimulant | 0.741 0.004 CID_154699657 | CID_154699657 | |
| 0.05 | 0.005 | 0.05 | Prostaglandin EP2 agonist | |||
| 0.121 | 0.079 | 0.121 | Cyclooxygenase 1 inhibitor | |||
| 0.111 | 0.069 | 0.177 | Protein-tyrosine phosphatase 1B inhibitor | 0.177 0.036 CID_154699657 | CID_154699657 | |
| 0.059 | 0.017 | 0.059 | NMDA receptor subunit 3A antagonist | |||
| 0.064 | 0.023 | 0.064 | Phosphorylase inhibitor | |||
| 0.053 | 0.013 | 0.053 | RNA-directed RNA polymerase stimulant | |||
| 0.074 | 0.034 | 0.335 | HIV-1 integrase (Strand Transfer) inhibitor | 0.335 0.004 CID_154699657 | CID_154699657 | |
| 0.086 | 0.046 | 0.086 | T cell inhibitor | |||
| 0.068 | 0.028 | 0.068 | Sphingosine kinase inhibitor | 0.06 0.038 CID_154699657 | ||
| 0.048 | 0.008 | 0.048 | Ceramide glucosyltransferase inhibitor | 0.04 0.017 CID_154699657 | ||
| 0.041 | 0.002 | 0.041 | Thromboxane A2 agonist | |||
| 0.134 | 0.097 | 0.134 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.07 | 0.032 | 0.07 | Biliverdin reductase inhibitor | |||
| 0.077 | 0.04 | 0.092 | Phospholipase D inhibitor | 0.092 0.02 CID_154699657 | CID_154699657 | |
| 0.127 | 0.09 | 0.127 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.08 | 0.044 | 0.08 | Glutamate dehydrogenase inhibitor | |||
| 0.082 | 0.046 | 0.082 | Phosphodiesterase 4D inhibitor | |||
| 0.099 | 0.063 | 0.099 | GABA C receptor rho-1 antagonist | |||
| 0.12 | 0.084 | 0.162 | Nav1.2 sodium channel blocker | 0.162 0.05 CID_154699657 | CID_154699657 | |
| 0.052 | 0.016 | 0.052 | Dopamine D5 agonist | |||
| 0.064 | 0.028 | 0.064 | Lipocortins synthesis agonist | |||
| 0.052 | 0.018 | 0.052 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.072 | 0.038 | 0.072 | Exportin-1 inhibitor | |||
| 0.205 | 0.171 | 0.429 | Antithrombotic | 0.429 0.042 CID_154699657 | CID_154699657 | |
| 0.045 | 0.011 | 0.045 | Prostaglandin agonist | |||
| 0.057 | 0.024 | 0.057 | CD45 antagonist | |||
| 0.079 | 0.045 | 0.079 | Telomerase inhibitor | |||
| 0.063 | 0.029 | 0.608 | NMDA 2B receptor antagonist | 0.608 0.003 CID_154699657 | CID_154699657 | |
| 0.043 | 0.01 | 0.043 | Cholesterol ester transfer protein antagonist | 0.038 0.014 CID_154699657 | ||
| 0.056 | 0.023 | 0.056 | Aldosterone antagonist | |||
| 0.13 | 0.098 | 0.13 | Insulin secretagoues | |||
| 0.063 | 0.032 | 0.063 | Ca(v)3.2 blocker | |||
| 0.041 | 0.01 | 0.041 | Estrogen-related receptor beta antagonist | |||
| 0.092 | 0.061 | 0.092 | Alcohol dehydrogenase inhibitor | |||
| 0.073 | 0.042 | 0.073 | Protein kinase C beta inhibitor | |||
| 0.053 | 0.022 | 0.053 | Sphingosine 1-phosphate receptor agonist | |||
| 0.062 | 0.032 | 0.062 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.038 | 0.008 | 0.038 | Sodium/glucose cotransporter inhibitor | |||
| 0.081 | 0.051 | 0.086 | Interferon agonist | 0.086 0.044 CID_154699657 | CID_154699657 | |
| 0.036 | 0.006 | 0.036 | Hedgehog signaling activator | |||
| 0.038 | 0.009 | 0.038 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.131 | 0.103 | 0.131 | GABA C receptor rho-2 antagonist | |||
| 0.113 | 0.085 | 0.113 | Toll-Like receptor 2 antagonist | |||
| 0.057 | 0.029 | 0.057 | Aconitate hydratase inhibitor | |||
| 0.063 | 0.037 | 0.063 | Acetylcholine M3 receptor antagonist | |||
| 0.102 | 0.075 | 0.102 | Mucolytic | |||
| 0.075 | 0.049 | 0.222 | CDC25A inhibitor | 0.222 0.005 CID_154699657 | CID_154699657 | |
| 0.047 | 0.021 | 0.047 | Thymidine kinase inhibitor | |||
| 0.033 | 0.008 | 0.033 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.048 | 0.022 | 0.048 | GABA B receptor antagonist | |||
| 0.081 | 0.056 | 0.081 | Carbonic anhydrase VI inhibitor | 0.072 0.07 CID_154699657 | ||
| 0.085 | 0.06 | 0.085 | Alpha 2 adrenoreceptor antagonist | |||
| 0.056 | 0.031 | 0.099 | Heparanase inhibitor | 0.099 0.004 CID_154699657 | CID_154699657 | |
| 0.218 | 0.194 | 0.218 | 15-Lipoxygenase inhibitor | |||
| 0.028 | 0.004 | 0.028 | Antibiotic Anthracycline-like | |||
| 0.026 | 0.003 | 0.026 | Thromboxane agonist | |||
| 0.107 | 0.084 | 0.107 | Acetylcholine antagonist | |||
| 0.038 | 0.015 | 0.038 | ATP citrate lysase inhibitor | |||
| 0.042 | 0.019 | 0.042 | Retinoid X alpha receptor agonist | |||
| 0.045 | 0.022 | 0.045 | Sphingosine kinase 1 inhibitor | |||
| 0.027 | 0.005 | 0.027 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.096 | 0.073 | 0.096 | Expectorant | |||
| 0.182 | 0.161 | 0.182 | Lipoxygenase inhibitor | |||
| 0.044 | 0.023 | 0.044 | Kainate receptor agonist | |||
| 0.062 | 0.04 | 0.062 | Alpha 2 adrenoreceptor agonist | |||
| 0.033 | 0.012 | 0.033 | Purinergic P2Y15 antagonist | |||
| 0.123 | 0.102 | 0.277 | Diuretic | 0.277 0.026 CID_154699657 | CID_154699657 | |
| 0.034 | 0.014 | 0.034 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.147 | 0.127 | 0.147 | Death-associated protein kinase 3 inhibitor | |||
| 0.04 | 0.02 | 0.04 | Glutamate (mGluR3) antagonist | |||
| 0.044 | 0.025 | 0.044 | Liver X receptor alpha agonist | |||
| 0.065 | 0.046 | 0.065 | Beta adrenoreceptor antagonist | |||
| 0.061 | 0.042 | 0.061 | Purinergic P2X1 antagonist | |||
| 0.023 | 0.005 | 0.023 | NMDA receptor phencyclidine site antagonist | |||
| 0.029 | 0.011 | 0.029 | Prostaglandin E2 agonist | |||
| 0.025 | 0.008 | 0.025 | Progesterone agonist | |||
| 0.066 | 0.05 | 0.066 | MDM2 inhibitor | |||
| 0.12 | 0.104 | 0.12 | Farnesoid X receptor antagonist | |||
| 0.117 | 0.102 | 0.117 | Cyclooxygenase inhibitor | |||
| 0.049 | 0.035 | 0.049 | Squalene epoxidase inhibitor | |||
| 0.069 | 0.055 | 0.069 | Aminopeptidase I inhibitor | |||
| 0.055 | 0.041 | 0.055 | 5 Hydroxytryptamine 7 agonist | |||
| 0.036 | 0.022 | 0.036 | HMG CoA reductase inhibitor | |||
| 0.107 | 0.093 | 0.107 | Cyclooxygenase 3 inhibitor | |||
| 0.038 | 0.024 | 0.038 | Delayed rectifier potassium channel blocker | |||
| 0.06 | 0.047 | 0.06 | Prostaglandin F2 alpha antagonist | |||
| 0.059 | 0.047 | 0.059 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.197 | 0.185 | 0.197 | Vasodilator, coronary | |||
| 0.062 | 0.05 | 0.067 | Interferon inducer | 0.067 0.04 CID_154699657 | CID_154699657 | |
| 0.02 | 0.008 | 0.02 | Telomerase stimulant | |||
| 0.036 | 0.025 | 0.036 | Retinoid X receptor agonist | |||
| 0.115 | 0.104 | 0.115 | Neurotrophic factor | |||
| 0.082 | 0.071 | 0.082 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.034 | 0.024 | 0.034 | Fumarate hydratase inhibitor | |||
| 0.034 | 0.024 | 0.034 | Tubulin agonist | |||
| 0.165 | 0.155 | 0.165 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.116 | 0.106 | 0.208 | Cell wall synthesis inhibitor | 0.208 0.027 CID_154699657 | CID_154699657 | |
| 0.051 | 0.042 | 0.051 | Leukotriene B4 antagonist | |||
| 0.023 | 0.014 | 0.023 | Adenosine kinase inhibitor | |||
| 0.022 | 0.013 | 0.022 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.021 | 0.011 | 0.021 | Progesterone receptor B antagonist | |||
| 0.229 | 0.22 | 0.229 | MAP kinase kinase 6 inhibitor | |||
| 0.019 | 0.011 | 0.019 | Free fatty acid receptor 1 agonist | |||
| 0.023 | 0.015 | 0.023 | Prostaglandin F2 alpha agonist | |||
| 0.036 | 0.028 | 0.036 | 5-Alpha-reductase inhibitor | |||
| 0.112 | 0.105 | 0.112 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.067 | 0.059 | 0.067 | Porphobilinogen synthase inhibitor | |||
| 0.05 | 0.043 | 0.05 | Acetylcholine muscarinic agonist | |||
| 0.098 | 0.092 | 0.175 | Acetylcholine release stimulant | 0.175 0.007 CID_154699657 | CID_154699657 | |
| 0.077 | 0.07 | 0.077 | Acetylcholine agonist | |||
| 0.035 | 0.029 | 0.035 | Farnesoid X receptor agonist | |||
| 0.066 | 0.061 | 0.066 | Glutamate decarboxylase inhibitor | |||
| 0.058 | 0.053 | 0.058 | CDC25B inhibitor | |||
| 0.058 | 0.053 | 0.058 | Dopamine D1 antagonist | |||
| 0.068 | 0.065 | 0.068 | GABA aminotransferase inhibitor | |||
| 0.016 | 0.014 | 0.016 | Alpha 2a adrenoreceptor agonist | |||
| 0.053 | 0.051 | 0.053 | Pregnane X receptor antagonist | |||
| 0.02 | 0.017 | 0.02 | Retinoid X beta receptor antagonist | |||
| 0.029 | 0.027 | 0.029 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.046 | 0.044 | 0.046 | Protein 50S ribosomal subunit inhibitor | |||
| 0.154 | 0.152 | 0.154 | Vasodilator | |||
| 0.019 | 0.018 | 0.089 | Estrone sulfatase inhibitor | 0.089 0.005 CID_154699657 | CID_154699657 | |
| 0.046 | 0.045 | 0.046 | Opioid agonist | |||
| 0.026 | 0.025 | 0.026 | HCV NS5A inhibitor | |||
| 0.041 | 0.04 | 0.041 | Adenosine deaminase inhibitor | |||
| 0.053 | 0.055 | 0.096 | NMDA 2C receptor antagonist | 0.096 0.017 CID_154699657 | CID_154699657 | |
| 0.023 | 0.028 | 0.256 | NMDA 2D receptor antagonist | 0.256 0.002 CID_154699657 | CID_154699657 | |
| 0.035 | 0.042 | 0.039 | Guanylate cyclase inhibitor | 0.039 0.035 CID_154699657 | CID_154699657 | |
| 0.05 | 0.059 | 0.352 | Selectin antagonist | 0.352 0.004 CID_154699657 | CID_154699657 | |
| 0.01 | 0.033 | 0.018 | Sodium/hydrogen exchanger inhibitor | 0.018 0.012 CID_154699657 | CID_154699657 | |
| 0.07 | 0.094 | 0.124 | Aminopeptidase B inhibitor | 0.124 0.05 CID_154699657 | CID_154699657 | |
| 0.045 | 0.076 | 0.238 | HIV-1 integrase (3'-Processing) inhibitor | 0.238 0.007 CID_154699657 | CID_154699657 | |
| 0.044 | 0.093 | 0.086 | Catalase inhibitor | 0.086 0.044 CID_154699657 | CID_154699657 | |
| 0.046 | 0.097 | 0.068 | Protease 3C (Human rhinovirus) inhibitor | 0.068 0.04 CID_154699657 | CID_154699657 | |
| 0.108 | 0.161 | 0.3 | Platelet adhesion inhibitor | 0.3 0.034 CID_154699657 | CID_154699657 | |
| 0.019 | 0.072 | 0.05 | Toll-Like receptor 4 agonist | 0.05 0.004 CID_154699657 | CID_154699657 | |
| 0.044 | 0.099 | 0.112 | Carbonic anhydrase XIII inhibitor | 0.112 0.033 CID_154699657 | CID_154699657 | |
| 0.013 | 0.104 | 0.033 | 1,3-Beta-glucan synthase inhibitor | 0.033 0.009 CID_154699657 | CID_154699657 | |
| 0.052 | 0.145 | 0.219 | Cell adhesion molecule inhibitor | 0.219 0.008 CID_154699657 | CID_154699657 | |
| 0.018 | 0.112 | 0.062 | Carbonic anhydrase VB inhibitor | 0.062 0.034 CID_154699657 | CID_154699657 | |
| 0.044 | 0.139 | 0.088 | HIV-1 integrase inhibitor | 0.088 0.033 CID_154699657 | CID_154699657 | |
| 0.093 | 0.197 | 0.279 | Hemostatic | 0.279 0.018 CID_154699657 | CID_154699657 | |
| 0.066 | 0.185 | 0.198 | Thrombolytic | 0.198 0.053 CID_154699657 | CID_154699657 | |
| 0.029 | 0.148 | 0.065 | Carbonic anhydrase VA inhibitor | 0.065 0.052 CID_154699657 | CID_154699657 | |
| 0.025 | 0.149 | 0.085 | Carbonic anhydrase V inhibitor | 0.085 0.033 CID_154699657 | CID_154699657 | |
| 0.037 | 0.161 | 0.1 | Adenine nucleotide translocase inhibitor | 0.1 0.004 CID_154699657 | CID_154699657 | |
| 0.064 | 0.225 | 0.161 | Cell adhesion inhibitor | 0.161 0.04 CID_154699657 | CID_154699657 | |
| 0.015 | 0.192 | 0.044 | Purinergic P2Y2 antagonist | 0.044 0.013 CID_154699657 | CID_154699657 | |
| 0.116 | 0.298 | 0.581 | Angiogenesis inhibitor | 0.581 0.019 CID_154699657 | CID_154699657 | |
| 0.016 | 0.295 | 0.073 | Neuraminidase (influenza) inhibitor | 0.073 0.031 CID_154699657 | CID_154699657 | |
| 0.033 | 0.414 | 0.376 | Dual specificity phosphatase 3 inhibitor | 0.376 0.017 CID_154699657 | CID_154699657 | |
| 0.03 | 0.444 | 0.373 | Dual specificity phosphatase inhibitor | 0.373 0.018 CID_154699657 | CID_154699657 | |
| 0.024 | 0.445 | 0.197 | Multidrug resistance-associated protein 1 inhibitor | 0.197 0.011 CID_154699657 | CID_154699657 | |
| 0.01 | 0.527 | 0.599 | Cholecystokinin B agonist | 0.599 0.002 CID_154699657 | CID_154699657 | |
| 0.018 | 0.566 | 0.555 | Anticoagulant | 0.555 0.007 CID_154699657 | CID_154699657 | |
| 0.021 | 0.62 | 0.111 | Nav1.4 sodium channel blocker | 0.111 0.061 CID_154699657 | CID_154699657 | |
| 0.003 | 0.608 | 0.17 | Cholecystokinin B antagonist | 0.17 0.004 CID_154699657 | CID_154699657 | |
| 0.013 | 0.695 | 0.144 | Factor IXa inhibitor | 0.144 0.004 CID_154699657 | CID_154699657 | |
| 0.003 | 0.722 | 0.238 | Cholecystokinin A antagonist | 0.238 0.004 CID_154699657 | CID_154699657 | |
| 0.003 | 0.728 | 0.169 | Cholecystokinin antagonist | 0.169 0.005 CID_154699657 | CID_154699657 | |
| 0.003 | 0.729 | 0.584 | Cholecystokinin agonist | 0.584 0.002 CID_154699657 | CID_154699657 | |
| 0.003 | 0.74 | 0.374 | Cholecystokinin A agonist | 0.374 0.002 CID_154699657 | CID_154699657 | |
| 0.004 | 0.891 | 0.049 | Elastase inhibitor | 0.049 0.043 CID_154699657 | CID_154699657 | |
| 0.004 | 0.909 | 0.065 | Thrombin inhibitor | 0.065 0.062 CID_154699657 | CID_154699657 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |